Evidence map›Paper›PMID 35292092›Full record

ReviewJournal of experimental & clinical cancer research : CR2022

LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond.

Wanxu Huang, Hua Li, Qingsong Yu, Wei Xiao, Dan Ohtan Wang

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of experimental & clinical cancer research : CR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 137 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Epigenetic regulation in a high-sugar environment (Review).International journal of molecular medicine · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Wanxu Huang *Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China. huangwx@syphu.edu.cn.ORCID http://orcid.org/0000-0002-9159-3678
Hua Li *Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Qingsong YuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China.
Wei XiaoState Key Laboratory of New-Tech for Chinese Medicine Pharmaceutical Process, Lianyungang, 222001, Jiangsu, China. xw_kanion@163.com.
Dan Ohtan WangWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China.

Funding

Department of Education of Liaoning Province 1911520092Key Technologies Research and Development Program 2021YFC2009302National Natural Science Foundation of China 31971335National Natural Science Foundation of China 32000426Xingliao Talents Program XLYC1802007
6 · The paper itself

Abstract

DNA methylation is one of the most important epigenetic mechanisms to regulate gene expression, which is highly dynamic during development and specifically maintained in somatic cells. Aberrant DNA methylation patterns are strongly associated with human diseases including cancer. How are the cell-specific DNA methylation patterns established or disturbed is a pivotal question in developmental biology and cancer epigenetics. Currently, compelling evidence has emerged that long non-coding RNA (lncRNA) mediates DNA methylation in both physiological and pathological conditions. In this review, we provide an overview of the current understanding of lncRNA-mediated DNA methylation, with emphasis on the roles of this mechanism in cancer, which to the best of our knowledge, has not been systematically summarized. In addition, we also discuss the potential clinical applications of this mechanism in RNA-targeting drug development.

Indexed as

DNA MethylationHumansNeoplasmsRNA, Long NoncodingRNA, Long NoncodingCancerDNA methylationDNMTlncRNANon-coding RNATET

Identifiers

PMID35292092
PMCPMC8922926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.